drugset / Trial / NCT01180465
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
RandomizedParallel-groupQuadruple-blindTreatment
Summary
LIPO-102 is under evaluation for treatment of abdominal adiposity
Timeline
- Start
- 2010-04
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LIPO-102 | Unknown | — | Subcutaneous |
Indications
No indication recorded.